Ann Dermatol.  2017 Jun;29(3):321-326. 10.5021/ad.2017.29.3.321.

In Vitro Anti-Malassezia Activity of Castanea crenata Shell and Oil-Soluble Glycyrrhiza Extracts

• Han SH
• Hur MS
• Kim MJ
• Jung WH
• Park M
• Kim JH
• Shin HJ
• Choe YB
• Ahn KJ
• Lee YW

• KMID: 2378532
• DOI: http://doi.org/10.5021/ad.2017.29.3.321

Abstract

BACKGROUND
A new shampoo with anti-Malassezia properties obtained from various plants is required to provide seborrheic dermatitis patients with a wider range of treatment options.
OBJECTIVE
The aim of this study was to obtain in vitro susceptibility profiles of Malassezia restricta and M. globosa, the most important pathogenic organisms in the development of seborrheic dermatitis, to the plant extracts used in commercial anti-dandruff shampoos.
METHODS
Minimal inhibitory concentrations (MICs) were determined for eight candidate plant extracts and two plant-derived natural products diluted with Leeming and Notman medium to final concentrations of 0.016 to 1 mg/ml.
RESULTS
Castanea crenata shell, Camellia sinensis leaf, and oil-soluble Glycyrrhiza extracts presented relatively low MIC values (≤0.5 mg/ml) against both strains. The C. crenata shell and oil-soluble Glycyrrhiza extracts demonstrated especially high anti-Malassezia activity, suggesting their potential use in the treatment of seborrheic dermatitis. The extracts also showed fungistatic activity against other common facultative pathogenic yeasts, Cryptococcus and Candida.
CONCLUSION
C. crenata shell and oil-soluble Glycyrrhiza extracts could potentially be used as active ingredients in anti-seborrheic and anti-dandruff shampoo formulations. They could be helpful for repeated treatments and regular prophylaxis of scalp seborrheic dermatitis.

Keyword

Castanea crenata shell extract; Malassezia; Oil-soluble Glycyrrhiza extract; Seborrheic dermatitis; Shampoo

MeSH Terms

Biological Products
Camellia sinensis
Candida
Cryptococcus
Dermatitis, Seborrheic
Glycyrrhiza*
Humans
In Vitro Techniques*
Malassezia
Plant Extracts
Scalp
Yeasts
Biological Products
Plant Extracts

Reference

1. Crespo Erchiga V, Delgado Florencio V. Malassezia species in skin diseases. Curr Opin Infect Dis. 2002; 15:133–142.

2. Gupta AK, Ryder JE, Nicol K, Cooper EA. Superficial fungal infections: an update on pityriasis versicolor, seborrheic dermatitis, tinea capitis, and onychomycosis. Clin Dermatol. 2003; 21:417–425.

3. Tajima M, Sugita T, Nishikawa A, Tsuboi R. Molecular analysis of Malassezia microflora in seborrheic dermatitis patients: comparison with other diseases and healthy subjects. J Invest Dermatol. 2008; 128:345–351.

4. Lee YW, Byun HJ, Kim BJ, Kim DH, Lim YY, Lee JW, et al. Distribution of malassezia species on the scalp in korean seborrheic dermatitis patients. Ann Dermatol. 2011; 23:156–161.

5. Guého E, Boekhout T, Ashbee HR, Guillot J, Van Belkum A, Faergemann J. The role of Malassezia species in the ecology of human skin and as pathogens. Med Mycol. 1998; 36:Suppl 1. 220–229.

6. Carrillo-Muñoz AJ, Rojas F, Tur-Tur C, de Los Ángeles Sosa M, Diez GO, Espada CM, et al. In vitro antifungal activity of topical and systemic antifungal drugs against Malassezia species. Mycoses. 2013; 56:571–575.

7. Turner GA, Matheson JR, Li GZ, Fei XQ, Zhu D, Baines FL. Enhanced efficacy and sensory properties of an anti-dandruff shampoo containing zinc pyrithione and climbazole. Int J Cosmet Sci. 2013; 35:78–83.

8. Kim YR, Kim JH, Shin HJ, Choe YB, Ahn KJ, Lee YW. Clinical evaluation of a new-formula shampoo for scalp seborrheic dermatitis containing extract of rosa centifolia petals and epigallocatechin gallate: a randomized, double-blind, controlled study. Ann Dermatol. 2014; 26:733–738.

9. Leeming JP, Notman FH. Improved methods for isolation and enumeration of Malassezia furfur from human skin. J Clin Microbiol. 1987; 25:2017–2019.

10. Sugita T, Tajima M, Ito T, Saito M, Tsuboi R, Nishikawa A. Antifungal activities of tacrolimus and azole agents against the eleven currently accepted Malassezia species. J Clin Microbiol. 2005; 43:2824–2829.

11. Piérard-Franchimont C, Goffin V, Decroix J, Piérard GE. A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis. Skin Pharmacol Appl Skin Physiol. 2002; 15:434–441.

12. Ratnavel RC, Squire RA, Boorman GC. Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis. J Dermatolog Treat. 2007; 18:88–96.

13. Arrese JE, Piérard-Franchimont C, De Doncker P, Heremans A, Cauwenbergh G, Piérard GE. Effect of ketoconazole-medicated shampoos on squamometry and Malassezia ovalis load in pityriasis capitis. Cutis. 1996; 58:235–237.

14. McGinley KJ, Leyden JJ, Marples RR, Kligman AM. Quantitative microbiology of the scalp in non-dandruff, dandruff, and seborrheic dermatitis. J Invest Dermatol. 1975; 64:401–405.

15. Nenoff P, Haustein UF. In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans. Acta Derm Venereol. 2002; 82:170–173.

16. Kim SY, Kim SH, Kim SN, Kim AR, Kim YR, Kim MJ, et al. Isolation and identification of Malassezia species from Chinese and Korean patients with seborrheic dermatitis and in vitro studies on their bioactivity on sebaceous lipids and IL-8 production. Mycoses. 2016; 59:274–280.

17. Georgopapadakou NH, Walsh TJ. Antifungal agents: chemotherapeutic targets and immunologic strategies. Antimicrob Agents Chemother. 1996; 40:279–291.

18. Alexander BD, Perfect JR. Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches. Drugs. 1997; 54:657–678.

19. Georgopapadakou NH. Antifungals: mechanism of action and resistance, established and novel drugs. Curr Opin Microbiol. 1998; 1:547–557.

20. Fatima A, Gupta VK, Luqman S, Negi AS, Kumar JK, Shanker K, et al. Antifungal activity of Glycyrrhiza glabra extracts and its active constituent glabridin. Phytother Res. 2009; 23:1190–1193.

21. Rigopoulos D, Ioannides D, Kalogeromitros D, Gregoriou S, Katsambas A. Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial. Br J Dermatol. 2004; 151:1071–1075.

22. du Vivier A. Tachyphylaxis to topically applied steroids. Arch Dermatol. 1976; 112:1245–1248.

23. Onlom C, Khanthawong S, Waranuch N, Ingkaninan K. In vitro anti-Malassezia activity and potential use in anti-dandruff formulation of Asparagus racemosus. Int J Cosmet Sci. 2014; 36:74–78.

24. Hahn HG, Oh HS, Cheon SH, Oak MH, Kim YR, Kim KM. Excavation of lead compounds that inhibit mast cell degranulation by combinatorial chemistry and activity-guided. Arch Pharm Res. 2004; 27:518–523.

25. Rohinishree YS, Negi PS. Effect of licorice extract on cell viability, biofilm formation and exotoxin production by Staphylococcus aureus. J Food Sci Technol. 2016; 53:1092–1100.

26. Sato J, Goto K, Nanjo F, Kawai S, Murata K. Antifungal activity of plant extracts against Arthrinium sacchari and Chaetomium funicola. J Biosci Bioeng. 2000; 90:442–446.